• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . CT changes of severe coronavirus disease 2019 based on prognosis

tetano

Editor, Senior Moderator
Sci Rep


. 2020 Dec 14;10(1):21849.
doi: 10.1038/s41598-020-78965-0.
CT changes of severe coronavirus disease 2019 based on prognosis


Bin Liang[SUP] 1 [/SUP], Lingli Xie[SUP] 2 [/SUP], Fan Yang[SUP] 1 [/SUP], Joyman Makamure[SUP] 1 [/SUP], Lijie Zhang[SUP] 1 [/SUP], Ran Pang[SUP] 3 [/SUP], Peng Du[SUP] 2 [/SUP], Wenhui Fan[SUP] 4 [/SUP], Chuansheng Zheng[SUP] 5 [/SUP]



Affiliations

Abstract

This study aimed to determine the characteristics of CT changes in patients with severe coronavirus disease 2019 (COVID-19) based on prognosis. Serial CT scans in 47 patients with severe COVID-19 were reviewed. The patterns, distribution and CT score of lung abnormalities were assessed. Scans were classified according to duration in weeks after onset of symptoms. These CT abnormalities were compared between discharged and dead patients. Twenty-six patients were discharged, whereas 21 passed away. Discharged patients were characterized by a rapid rise in CT score in the first 2 weeks followed by a slow decline, presence of reticular and mixed patterns from the second week, and prevalence of subpleural distribution of opacities in all weeks. In contrast, dead patients were characterized by a progressive rise in CT score, persistence of ground-glass opacity and consolidation patterns in all weeks, and prevalence of diffuse distribution from the second week. CT scores of death group were significantly higher than those of discharge group (P < 0.05). The CT changes differed between the discharged and dead patients. An understanding of these differences can be of clinical significance in the assessment of the prognosis of severe COVID-19 patients.
 
Back
Top Bottom